Urinary Liver-Type Fatty Acid-Binding Protein Predicts Residual Renal Function Decline in Patients on Peritoneal Dialysis

Kenta Torigoe; Kumiko Muta; Kiyokazu Tsuji; Ayuko Yamashita; Yuki Ota; Mineaki Kitamura; Hiroshi Mukae; Tomoya Nishino

doi:10.12659/MSM.928236

21 December 2020 : Clinical Research

Urinary Liver-Type Fatty Acid-Binding Protein Predicts Residual Renal Function Decline in Patients on Peritoneal Dialysis

Kenta Torigoe^1ABCDEF, Kumiko Muta^1ABCDEF*, Kiyokazu Tsuji^1B, Ayuko Yamashita^1B, Yuki Ota^1B, Mineaki Kitamura^1DE, Hiroshi Mukae^2G, Tomoya Nishino^1ADEG

DOI: 10.12659/MSM.928236

Med Sci Monit 2020; 26:e928236

Authors information Article notes Copyright and License information

Related articles Order reprints Share article Share by email

View HTML version

Table 3 Multiple logistic regression analysis of RRF decline in patients on PD.

	Odds ratio	95% confidence interval	P value
Urinary L-FABP (μg/d)	1.03	1.00–1.05	0.001
Urinary protein (g/d)	6.04	0.19–8.02	0.295
L-FABP – L-type fatty acid-binding protein; PD – peritoneal dialysis; RRF – residual renal function.

Back to the Article

Urinary Liver-Type Fatty Acid-Binding Protein Predicts Residual Renal Function Decline in Patients on Peritoneal Dialysis

Your Privacy